Net Cash Provided by (Used in) Operating Activities |
-1.26M |
USD |
-291% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-298K |
USD |
-185% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-2.09M |
USD |
-3324% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
250M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
9.68M |
shares |
+25% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-3.65M |
USD |
-10770% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
1.99M |
USD |
+174% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
1.99M |
USD |
+174% |
Q4 2024 |
FY 2024 |
Depreciation |
3.75K |
USD |
-4.73% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.99M |
USD |
+174% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Authorized |
25M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
15.2M |
USD |
+111% |
Q2 2025 |
Q2 2025 |
Depreciation, Depletion and Amortization |
2.41K |
USD |
+346% |
Q1 2023 |
Q1 2023 |
Interest Expense |
73.5K |
USD |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |